An epigenetically distinct HSC subset supports thymic reconstitution
Harold K. Elias(Memorial Sloan Kettering Cancer Center), Marcel R.M. van den Brink(City Of Hope National Medical Center), Brianna Gipson(Memorial Sloan Kettering Cancer Center), Cynthia E. Dunbar(National Heart Lung and Blood Institute), Marina Burgos da Silva(Memorial Sloan Kettering Cancer Center), Melody Smith(Memorial Sloan Kettering Cancer Center), Susan DeWolf(Memorial Sloan Kettering Cancer Center), Avinash Bhandoola(Center for Cancer Research), Anastasia I. Kousa(City Of Hope National Medical Center), Christopher Y. Park(University of Michigan), Xiaoqun Zhang(Memorial Sloan Kettering Cancer Center), Roshan Sharma(Memorial Sloan Kettering Cancer Center), Hana Andrlová(Memorial Sloan Kettering Cancer Center), Adhithi Rajagopalan(Memorial Sloan Kettering Cancer Center), Joseph C. Sun(Memorial Sloan Kettering Cancer Center), Christina S. Leslie(Memorial Sloan Kettering Cancer Center), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Simon Grassman(Memorial Sloan Kettering Cancer Center), Teng Fei(Wuhan University), Mohamed Ashraf Ali(Madras Medical College), Nicole Lee(Monash University), Sneha Mitra(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Gene therapy comes of age
|Science|2018|1.4k